Associate Director, Managed Access Programs, Medical Evidence Generation at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Degree in a relevant field (e.g., life sciences, pharmacy, public health) with at least 2 years of experience in managed access required. Advanced degree preferred
Proven experience with managed access programs and demonstrated experience with managing vendors
Previous experience in clinical operations and the drug development process is preferred
In-depth knowledge of global and local regulations and guidelines related to managed access programs (including post-study drug access)
Excellent communication, interpersonal and presentation skills
Proven history of leading through influence and working across complex, global organizational matrices
Ability to thrive in a fast-paced, dynamic environment and manage multiple priorities. Initiative-taking, assertive, and confident to act with urgency. Proven ability to work with a high level of integrity, accuracy, and attention

Responsibilities

Program operations and oversight: support the set-up and execution of managed access programs across multiple geographies; co-develop, review, and maintain program-related documents (such as protocol, informed consent forms, treatment plans); monitor overall program performance
Vendor & Partner management: set-up, review and ongoing management of Statement of Work, oversee third-party vendors providing operational services, ensuring high-quality delivery against agreed timelines and metrics; function as a point of contact for external partners to ensure smooth coordination and issue resolution
Cross-functional collaboration: partner with internal stakeholders (clinical supply, safety, quality, local medical) to ensure compliant program execution and facilitate alignment across functions to resolve operational challenges and maintain program continuity
Metrics, reporting and compliance: track and report program metrics (number of countries, sites, patients; ensure consistent and accurate monthly reporting), ensuring accuracy of patient numbers and key milestones
Strategic contribution: provide input into strategic decision-making based on operational insights and overall managed access experience

Skills

Program Management

Project Management

Cross-Functional Collaboration

Protocol Development

Informed Consent Forms

Treatment Plans

Global Operations

Regulatory Compliance

Operational Excellence

Patient Access Programs

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free